Morgan Hanger, Director of Strategic Programs is leading a new initiative to develop a parsimonious set of metrics to assess, monitor, and analyze the progress of the clinical trial enterprise towards CTTI’s Transforming Trials 2030 vision, as well as advising on CTTI strategy and operations.
Speaking In
11:00 AM - 12:00 PM
Tuesday, June 6
BIO DOUBLE HELIX SPONSORS
BIO HELIX SPONSORS
